News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Prolysis Limited Appoints Bioscience Managers Limited As Corporate Finance Advisors For Its Series B Financing



10/19/2005 5:09:00 PM

Prolysis Ltd, a private company focused on the discovery and development of novel antibiotic therapies, has announced that it has appointed Bioscience Managers Limited (BML) as its corporate finance advisor for its Series B financing. BML will lead the marketing and closing of this venture round to assist Prolysis move its programs towards clinical development.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES